Stock BIOVERATIV INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Bioverativ Inc

Equities

US09075E1001

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sanofi : sees new acquisitions and drugs reviving growth
RE
Takeda Pharmaceutical : Merits of any Takeda bid for Shire questioned, shares slide
RE
Takeda Pharmaceutical : Merits of any Takeda bid for Shire questioned, shares slide
RE
Takeda Pharmaceutical : Drugmaker Shire soars as Japan's Takeda considers bid
RE
Bioverativ : Announces First Patient Dosed in Phase 3 Study of BIVV009 for Treatment of Cold Agglutinin Disease
BU
Bioverativ : Oxford BioMedica wins second $100 million gene therapy contract
RE
Bioverativ : Haemophilia Publishes a Retrospective Analysis Investigating the Use of ELOCTATE® for Immune Tolerance Induction in People with Inhibitors and Severe Hemophilia A
BU
Bioverativ : Reports Fourth Quarter and Full Year 2017 Performance
BU
Ablynx : Sanofi's return to profit growth this year slower than hoped
RE
Ablynx : Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom
RE
WeissLaw LLP : Investigates Bioverativ Inc. Acquisition
PR
Stocks hit record as senators reach deal to end shutdown
RE
Compagnie Financiere Richemont : Dealmaking drives European stocks as equity melt-up continues
RE
Bragar Eagel & Squire, P.C. : is Investigating the Board of Directors of Bioverativ Inc. (BIVV) on Behalf of Stockholders and Encourages Investors to Contact the Firm
BU
Ablynx : Biotech M&A takes off as Sanofi and Celgene spend $20 billion
RE
Biogen : Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion
RE
Bioverativ : New drugs recast $10 billion haemophilia market as Sanofi swoops in
RE
Biogen : Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion
RE
Biogen : Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion
RE
Bioverativ : Sanofi shares fall on $11.6 billion Bioverativ takeover
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Bioverativ Inc